Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy—histomorphometric and immunohistochemical analysis
Authors:
- 9 March 2016
- journal article
- research article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 21 (1) , 199-210
Abstract
Objective This study aimed to investigate the effect of hyperbaric oxygen therapy (HBOT) on tooth extraction sites in rats treated with bisphosphonate. Materials and methods Rats were treated with zoledronic acid, subjected to tooth extractions and allocated into groups: (1) 7 days of HBOT, (2) 14 days of HBOT, (3) 7-day control, and (4) 14-day control. The site of tooth extractions was analyzed by histomorphometry and immunohistochemistry. Results On macroscopic analysis, HBOT did not significantly affect bone exposure volume either at 7 or 14 days. On hematoxylin and eosin (H&E) analysis, the 14-day HBOT group showed less non-vital bone compared to both controls and 7-day HBOT group. HBOT significantly lowered expression of vascular endothelial growth factor (VEGF), receptor activator NF-kB ligand (RANKL), bone morphogenetic protein-2 (BMP-2), and osteoprotegerin (OPG) at 7 days, compared to control, whereas at 14 days, there was no significant difference for these variables. Conclusion HBOT can reduce the amounts of non-vital bone microscopically detected in tooth extraction sites of rats subjected to bisphosphonate therapy. The effect seems to occur in a dose-dependent mode. Further studies are required to clarify the mechanisms accounting for this effect. Clinical relevance Treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) has been a challenging task, where the effectiveness of HBOT is controversial. This study reports important effects of HBOT on the maxillae of rats subjected to bisphosphonate treatment, making an important contribution to the knowledge about the applicability of HBOT in BRONJ.Keywords
This publication has 84 references indexed in Scilit:
- Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?Lasers in Medical Science, 2011
- Management of Osteonecrosis of the Jaws in Patients With History of Bisphosphonates TherapyJournal of Craniofacial Surgery, 2010
- Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique featuresJournal of Translational Medicine, 2010
- Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in miceJournal of Bone and Mineral Metabolism, 2009
- Oxidative stress is fundamental to hyperbaric oxygen therapyJournal of Applied Physiology, 2009
- Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivoJournal of Applied Physiology, 2009
- TOPICAL OXYGEN THERAPY INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND IMPROVES CLOSURE OF CLINICALLY PRESENTED CHRONIC WOUNDSClinical and Experimental Pharmacology and Physiology, 2008
- Pharmacokinetics/Pharmacodynamics of BisphosphonatesClinical Pharmacokinetics, 2005
- Infectious AngiogenesisThe American Journal of Pathology, 2003
- Bisphosphonates Pamidronate and Zoledronic Acid Stimulate Osteoprotegerin Production by Primary Human OsteoblastsBiochemical and Biophysical Research Communications, 2002